CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 53.78K | $26.72M | +1 | −1 |
| Q2 2026 | 131 | +6 | 8.89M | $4.13B | +9 | −4 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 319.65K | n/a | $173.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 174.70K | n/a | $94.79M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 68.52K | n/a | $37.18M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 4 | Renaissance Technologies ✦ | 61.80K | n/a | $33.53M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 60.93K | n/a | $33.06M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | AQR Capital Management ✦ | 52.09K | n/a | $28.26M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 42.00K | n/a | $22.79M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 40.36K | n/a | $21.90M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 39.34K | n/a | $21.35M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 28.82K | n/a | $15.64M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 22.29K | n/a | $12.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 21.83K | n/a | $11.84M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 19.27K | n/a | $10.46M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 16.61K | n/a | $9.01M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 7.99K | n/a | $4.34M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 486 holders, 12.67M shares, $4.47B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 2.00K sh · $1.03M
Officer, Director · 2.00K sh · $1.00M
Officer, Director · 2.00K sh · $1.08M
Officer · 1.00K sh · $541,040
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology